Siwen Liu

ORCID: 0000-0003-1398-0143
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related molecular mechanisms research
  • Lung Cancer Treatments and Mutations
  • Cancer-related cognitive impairment studies
  • RNA modifications and cancer
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Research Studies
  • IL-33, ST2, and ILC Pathways
  • MicroRNA in disease regulation
  • Glioma Diagnosis and Treatment
  • Dementia and Cognitive Impairment Research
  • Drug Transport and Resistance Mechanisms
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Mycobacterium research and diagnosis
  • Atherosclerosis and Cardiovascular Diseases
  • Cancer Immunotherapy and Biomarkers
  • Genetic factors in colorectal cancer
  • Ruminant Nutrition and Digestive Physiology
  • Cancer therapeutics and mechanisms
  • Circular RNAs in diseases
  • Cancer Genomics and Diagnostics
  • Eosinophilic Esophagitis
  • Advanced Neuroimaging Techniques and Applications
  • Cerebrovascular and Carotid Artery Diseases
  • Cytokine Signaling Pathways and Interactions
  • Brain Metastases and Treatment

Nanjing Medical University
2015-2025

Jiangsu Cancer Hospital
2016-2025

Beijing Biocytogen (China)
2025

Second Affiliated Hospital of Jilin University
2025

Guangdong Academy of Agricultural Sciences
2023

Ministry of Agriculture and Rural Affairs
2023

Heilongjiang Bayi Agricultural University
2022

Xuzhou Medical College
2021

Chinese Academy of Geological Sciences
2017

Chongqing Medical University
2016

Exosomes derived from lung cancer cells confer cisplatin (DDP) resistance to other cells. However, the underlying mechanism is still unknown. A549 DDP (A549/DDP) was established. Microarray used analyze microRNA (miRNA) expression profiles of cells, A549/DDP exosomes, and exosomes. There a strong correlation miRNA between exosomes their maternal A total 11 miRNAs were significantly upregulated both in compared with contrast 31 downregulated also observed. miR-100-5p most prominent decreased...

10.2147/ijn.s131516 article EN cc-by-nc International Journal of Nanomedicine 2017-05-01

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death. This study aimed to examine roles DHRS4-AS1/miR-224-3p signaling in stemness NSCLC. Real-time PCR showed that DHRS4-AS1 was downregulated cancerous tissues, and bioinformatics analysis revealed high expression indicated a good prognosis for NSCLC patients. Sphere colony formation assays overexpression significantly suppressed stem cell-like properties. also abrogated OCT4, SOX2, CD34, CD133, markedly inhibited...

10.3389/fcell.2020.585251 article EN cc-by Frontiers in Cell and Developmental Biology 2020-12-23

Abstract Most of the patients with lung cancer are diagnosed at advanced stage, and they often lose opportunity surgical therapy, most whom fail to reach good prognosis after chemotherapy. Recently, a few clinical studies have confirmed role adoptive T-cell transfer in maintenance therapy patients. Here, we provided statistical insights into CIKs from three different levels, cell model (in vitro co-culture system), mice situ cancer), research progression stages). We optimized components...

10.1038/s41419-018-0404-5 article EN cc-by Cell Death and Disease 2018-03-06

Abstract Background Rupture of atherosclerotic plaque can cause acute malignant heart and cerebrovascular events, such as coronary disease, stroke so on, which seriously threaten the safety human life property. Therefore, early diagnosis inhibition progress still be a vital task. Results In this study, we presented development composite mesoporous silica nanoparticle (Ru(bpy) 3 @SiO 2 -mSiO , CMSN)-based nanomedicines (NMs) @SRT1720@AntiCD36, CMSN@SRT@Anti) for accurate treatment...

10.1186/s12951-021-00962-w article EN cc-by Journal of Nanobiotechnology 2021-07-28

Abstract To gain an insight into the molecular mechanisms of cetuximab resistance in colorectal cancer, we generated a cetuximab‐resistant cell line (H508/ CR ) and performed RNA sequencing to identify differential expression patterns noncoding s (nc s) mRNA between cetuximab‐sensitive resistant cells. A total 278 nc transcripts 1,059 were dysregulated The levels nine selected long (lnc validated using quantitative real‐time PCR . Functional analysis revealed that several groups lnc might be...

10.1002/cam4.2004 article EN cc-by Cancer Medicine 2019-03-07

Object: To identify genes of prognostic value which associated with tumor microenvironment (TME) in acute myeloid leukemia (AML). Methods and materials: Level 3 AML patients gene transcriptome profiles were downloaded from The Cancer Genome Atlas (TCGA) database. Clinical characteristics survival data extracted the Genomic Data Commons (GDC) tool. Then, limma package was utilized for normalization processing. ESTIMATE algorithm used calculating immune, stromal scores. We examined...

10.3389/fonc.2019.01509 article EN cc-by Frontiers in Oncology 2020-01-21

Lung cancer is one of the most fatal malignancies and leading cause death worldwide. β-Elemene, a well-known anticancer drug, has drawn great deal attention from researchers attributed to its limited side impacts. N6-Methyladenosine (m6A) modification common RNA plays vital role in pathogenesis multiple tumors. However, functional link between β-elemene m6A lung development remains unexplored. In this study, we investigated whether was responsible for impacts on cancer. Firstly, outcomes...

10.1155/2022/3472745 article EN Journal of Oncology 2022-01-12

This study aims to evaluate the influence of rumen-protected methionine (RPM) on milk yield and compositions dairy cows by employing a meta-analysis method. The articles in publication databases between January 2010 2022 which reported various concentrations RPM supplements cow diets then monitored were searched. A total 14 studies included, covering 27 treatments with 623 cows. Comprehensive Meta-Analysis V3 was used for statistical analysis, forest map drawn standard mean difference (SMD)...

10.3390/ani12121505 article EN cc-by Animals 2022-06-09

Objective: This study aimed to explore the clinical efficacy and safety of durvalumab combined with albumin-bound paclitaxel carboplatin as neoadjuvant therapy for resectable stage III Non-small Cell Lung Cancer (NSCLC). Methods: A single-arm open-label phase Ib was conducted. total 40 patients driver gene-negative NSCLC were enrolled. All received treatment in combination carboplatin. The efficacy, Major Pathological Response (MPR), Complete (pCR), assessed. Flow cytometry used detect...

10.2174/0115748928304000240429120252 article EN Recent Patents on Anti-Cancer Drug Discovery 2025-01-06

Abstract Background Diagnostic methods for urothelial cancer (UC) are often invasive, while urinary cytology, a non-invasive alternative, suffers from limited sensitivity. This study aimed to identify differentially methylated markers in tumor DNA and develop diagnostic method enhance the sensitivity of UC detection. Methods Whole-genome bisulfite sequencing deep methylation were employed significantly hypermethylated UC-associated genes clinical samples public datasets. Further screening...

10.1186/s12935-025-03766-2 article EN cc-by Cancer Cell International 2025-04-15

The objective of this study is to evaluate the predictive value quantitative parameters from spectral CT for Ki-67 expression in ovarian cancer (OC). Spectral imaging data 39 patients with by pathology, encompassing 52 lesions overall, were collected retrospectively and split into two groups based on immunohistochemical results. Tumor solid components arterial, venous, delayed phases can be measured using post-processing software obtain CT. An independent sample t-test was implemented...

10.3389/fonc.2025.1576690 article EN cc-by Frontiers in Oncology 2025-05-14

Endogenous bornavirus-like nucleoprotein elements (EBLNs) have been discovered in the genomes of various animals including humans, whose functions seldom studied. To explore biological human EBLNs, we constructed a lentiviral vector expressing short-hairpin RNA against EBLN1, which successfully inhibited EBLN1 expression by above 80% infected oligodendroglia cells (OL cells). We found that silencing suppressed cell proliferation, induced G2/M phase arrest, and promoted apoptosis OL cells....

10.3390/ijms17040435 article EN International Journal of Molecular Sciences 2016-03-24

Colorectal cancer (CRC) is the fifth leading cause of cancer-related death in China. The incidence Chinese CRC has increased dramatically with changes dietary and lifestyle. However, genetic landscape colorectal mutation still poorly understood. In this study, we have performed whole exome-sequencing analysis 63 cases. We found that were hypermutated, which enriched ECM-receptor interaction, antigen processing presentation, focal adhesion. Analysis clinical characteristics indicated...

10.7150/jca.37017 article EN cc-by-nc Journal of Cancer 2019-12-13

Aim: This study was designed to investigate the predictive and prognostic values of serum vascular endothelial growth factor (VEGF) level in non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. Methods: Patients' peripheral blood samples were collected prior chemotherapy after 1 week third cycle combination Serum VEGF levels evaluated through Luminex multiplex technique. Between September 2011 August 2015, a total 135 consecutive advanced or recurrent...

10.2147/ott.s124124 article EN OncoTargets and Therapy 2017-01-01

Non-small cell lung cancer (NSCLC) is one of the leading causes cancer-related deaths, and it also most frequently diagnosed cancer. Previous studies indicate that IL-33 plays a crucial role in development NSCLC. In recent years, miRNAs has become increasingly clear. However, reports focused on relation between NSCLC have been limited.The expression miR-128-3p was detected by qPCR. MTT, EdU, colony formation assays were used to detect proliferation ability cells. Transwell assay investigate...

10.2147/cmar.s276297 article EN cc-by-nc Cancer Management and Research 2021-03-01

Chemotherapy-induced cognitive impairment (CICI), termed "chemobrain", is highly prevalent in cancer patients following the administration of chemotherapeutic agents. However, potential pathophysiological mechanisms underlying CICI remain unknown. This study aimed to explore functional changes brain and associated non-small cell lung (NSCLC) receiving different chemotherapy regimen.A total 49 NSCLC (25 pemetrexed plus carboplatin (PeCC) 24 paclitaxel (PaCC)) 61 healthy controls (HCs) were...

10.3389/fonc.2022.1027515 article EN cc-by Frontiers in Oncology 2022-11-02

To understand the mechanism involved in gefitinib resistance, we established gefitinib-resistant human HCC827/GR-8-1 cell line from parental HCC827 line. We compared micro-RNA expression profiles of cells using Agilent microarrays. The micro-RNAs, such as miR-149-5p, were up- or downregulated and associated with acquired resistance. Quantitative real-time polymerase chain reaction was then performed to verify patterns different micro-RNAs. result showed that miR-149-5p upregulated...

10.1177/1010428317691659 article EN cc-by-nc Tumor Biology 2017-03-01

Emotional distress frequently occur in cancer patients following diagnosis. Previous neuroimaging studies have demonstrated that depression and anxiety are associated with functional structural brain abnormalities. However, little is known about the cancer-associated changes of emotional network non-small cell lung (NSCLC) patients. The aim this study was to assess topological features emotions non-nervous system metastatic NSCLC prior chemotherapy.Twenty-four treatment-naïve 25 healthy...

10.21037/tlcr-20-273 article EN Translational Lung Cancer Research 2020-08-01

Cancer and chemotherapy are correlated with brain functional structural changes in cancer patients, which may lead to cognitive dysfunction. However, little is known about the abnormalities of patients non-small cell lung (NSCLC). The aim this study was explore topological properties within white matter network NSCLC prior chemotherapy.To neurobiological biomarkers NSCLC, magnetic resonance imaging (MRI) data were acquired 24 non-nervous system metastatic 25 matched healthy controls....

10.1080/00207454.2020.1813130 article EN International Journal of Neuroscience 2020-10-27

The recent research shows that the inhibition of nuclear factor-κB (NF-κB) pathway is a promising therapeutic option for patients who progress after treatment with novel mutant-selective EGFR-TKIs. For propose to find nontoxic drug reverse acquired gefitinib resistance, we examined whether Liver X Receptors agonist GW3965 affect resistance HCC827/GR-8-2 cells. Cell viability was measured by CCK-8 assay. Levels NF-κB, p-AKT and caspases were detected Western blot analysis. Immunocytochemical...

10.18632/oncotarget.15007 article EN Oncotarget 2017-02-02

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are efficient in treating patients with non-small cell lung cancer (NSCLC) harboring EGFR activating mutations. Unfortunately, nearly all ultimately acquire resistance to EGFR-TKI treatment. Liver X receptors (LXRs) can regulate tumor various lines. The present study indicated that LXR agonist combined gefitinib weakened Akt-nuclear (NF)-κB activation and inhibited the expression levels of apoptosis-related proteins...

10.3892/ol.2018.8182 article EN Oncology Letters 2018-03-06

Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is effective in lung cancer patients carrying sensitive EGFR mutations. In this study, we investigated if liver X receptor (LXR) agonist T0901317 could reverse the resistance of cell lines A549 and H1650 to EGFR-TKI treatment. We found that make natural EGFR-TKI-resistant human cells treatment was dependent on LXRβ expression. However, does not have a similar effect another line H1650.

10.1002/2211-5463.12147 article EN cc-by FEBS Open Bio 2016-10-24
Coming Soon ...